Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Stanford researchers test drug to fight depression faster in elderly


Elderly people who suffer from depression can take the edge off faster by using a drug called mirtazapine, which appears to work more quickly compared to rival drugs. These results come from a study by researchers at Stanford University Medical Center who compared two drugs in an eight-week trial. Although both drugs treated the depression, mirtazapine began working sooner and eased the patient’s anxiety - a common effect of depression in elderly people.

"There’s a sense that we need something else for elderly patients and here is an alternative that is well tolerated," said Alan Schatzberg, MD, the Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences. "It gives doctors an alternative."

Anti-depression drugs come in two common varieties. Selective serotonin reuptake inhibitors (SSRIs), such as the popular Zoloft and Prozac, cause the brain chemical serotonin to linger in the gaps between neurons. These drugs are extremely effective but can interact with other drugs such as beta-blockers, which many elderly people take to quell heart problems.

The alternative to SSRIs - tricyclic antidepressants (TCAs) - can have side effects that make them less appealing. However, mirtazapine, a non-tricyclic that works similarly to TCA’s, has few side effects or drug interactions. "Mirtazapine has TCA-like properties without the side effects," Schatzberg said. "A lot of people use it where they might have used a TCA, particularly in the elderly." Mirtazapine enhances the effects of serotonin and other brain chemicals and also acts as a mild sedative.

Schatzberg tested mirtazapine’s effectiveness against paroxetine (sold under the name Paxil), a popular SSRI. In his trial, 255 depressed people 65 or older were randomly divided into groups taking either mirtazapine or paroxetine. Psychiatrists analyzed the patients’ depression throughout an eight-week test period.

Although the drugs were equally effective by the end of the eight-week period, depression in patients on mirtazapine had eased significantly by day 14 compared with people taking paroxetine. Those patients also had less anxiety and an easier time sleeping. In addition, those who took mirtazapine had fewer side effects such as nausea, tremors or flatulence - side effects that caused 26 percent of those taking paroxetine to discontinue the trial compared with 15 percent of those on mirtazapine. During an extended eight-week phase after the initial trial, the two drugs remained equally effective.

Schatzberg said mirtazapine is also effective more quickly than SSRIs in younger people; however younger people are less likely to stay on the drug because it can cause some weight gain and grogginess. "Weight gain is a problem for younger patients," Schatzberg said. "There’s less initiative to use the drug in these people."

These side effects that drive younger patients away can be a boon to the elderly who are less concerned about their weight but who suffer from anxiety and insomnia. "Depressed people who are older often have agitation," Schatzberg said. "Mirtazapine calmed these patients and helped them sleep, especially early on."

Schatzberg said that many doctors already use mirtazapine to treat depression in their elderly patients in order to avoid the drug interactions that are common with SSRIs. "But it certainly hasn’t saturated the market in the elderly," he noted.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. For more information, please visit the Web site of the medical center’s Office of Communication & Public Affairs at

Amy Adams | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht NIH scientists describe potential antibody treatment for multidrug-resistant K. pneumoniae
14.03.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Researchers identify key step in viral replication
13.03.2018 | University of Pittsburgh Schools of the Health Sciences

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Locomotion control with photopigments

Researchers from Göttingen University discover additional function of opsins

Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...

Im Focus: Surveying the Arctic: Tracking down carbon particles

Researchers embark on aerial campaign over Northeast Greenland

On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...

Im Focus: Unique Insights into the Antarctic Ice Shelf System

Data collected on ocean-ice interactions in the little-researched regions of the far south

The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...

Im Focus: ILA 2018: Laser alternative to hexavalent chromium coating

At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.

When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...

Im Focus: Radar for navigation support from autonomous flying drones

At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.

Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...

All Focus news of the innovation-report >>>



Industry & Economy
Event News

Ultrafast Wireless and Chip Design at the DATE Conference in Dresden

16.03.2018 | Event News

International Tinnitus Conference of the Tinnitus Research Initiative in Regensburg

13.03.2018 | Event News

International Virtual Reality Conference “IEEE VR 2018” comes to Reutlingen, Germany

08.03.2018 | Event News

Latest News

Wandering greenhouse gas

16.03.2018 | Earth Sciences

'Frequency combs' ID chemicals within the mid-infrared spectral region

16.03.2018 | Physics and Astronomy

Biologists unravel another mystery of what makes DNA go 'loopy'

16.03.2018 | Life Sciences

Science & Research
Overview of more VideoLinks >>>